LAVA Therapeutics N.V.
Hedge Funds Holdings

Last updated:

LAVA Therapeutics N.V.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 3.55% of the total amount of its stocks outstanding. This makes up a total of 919.25K shares of LAVA Therapeutics N.V.. Compared to the previous quarter, the number fell by -87.75% or -6.58M shares fewer. As for the holding position changes, 42.86% (3) of current hedge fund investors increased the number of shares held, 14.29% (1) of current holders sold a part of the shares held, and 14.29% (1) closed the holdings completely. 1 hedge funds are new holders of LAVA Therapeutics N.V. stock in Q1 2023, it is 14.29% of total holders.

Hedge funds holding LAVA Therapeutics N.V. (Q1 2021 – Q1 2023)

Number of hedge funds
Q1 2021 24
Q2 2021 18
Q3 2021 18
Q4 2021 18
Q1 2022 16
Q2 2022 16
Q3 2022 12
Q4 2022 19
Q1 2023 7

Hedge funds changes in LAVA Therapeutics N.V. positions (Q1 2021 – Q1 2023)

Changes in positions
Q1 2021 240000
Q2 2021 44710-7
Q3 2021 52650
Q4 2021 22635
Q1 2022 03427
Q2 2022 11815
Q3 2022 22260
Q4 2022 81415
Q1 2023 13111

Top 50 hedge fund holders of LAVA Therapeutics N.V. (NASDAQ:LVTX)

Hedge fund Value Shares owned Portfolio share
NOVO HOLDINGS A/S 15.20M 3.32M 0.725%
REDMILE GROUP, LLC 12.87M 2.81M 0.499%
SILVERARC CAPITAL MANAGEMENT, LLC 2.79M 610.80K 0.944%
AXA S.A. 1.04M 228.67K 0.004%
ARTAL GROUP S.A. 914K 200K 0.039%
ALPHA WAVE GLOBAL, LP 554K 121.19K 0.066%
UBS OCONNOR LLC 343K 75K 0.006%
MILLENNIUM MANAGEMENT LLC Israel Englander 179K 39.16K 0.000%
CANNELL CAPITAL LLC 82K 17.95K 0.019%
GEODE CAPITAL MANAGEMENT, LLC 50K 11.12K 0.000%
MORGAN STANLEY 23K 5K 0.000%
TSFG, LLC 2K 400 0.001%
BANK OF NEW YORK MELLON CORP 0 0 0.000%
DAFNA CAPITAL MANAGEMENT LLC 0 0 0.000%
NICHOLAS INVESTMENT PARTNERS, LP 0 0 0.000%
POINT72 ASSET MANAGEMENT, L.P. Steven Cohen 0 0 0.000%
NANTAHALA CAPITAL MANAGEMENT, LLC 0 0 0.000%
UBS GROUP AG 0 0 0.000%